Urogen Pharma Ltd
SWB:UR8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
Urogen Pharma Ltd
SWB:UR8
|
IL |
|
Abbisko Cayman Ltd
F:8ZD
|
CN |
|
Immofinanz AG
LSE:0PAN
|
AT |
Wall St Price Targets
UR8 Price Targets Summary
Urogen Pharma Ltd
According to Wall Street analysts, the average 1-year price target for UR8 is 52.56 EUR with a low forecast of 41.64 EUR and a high forecast of 67.64 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UR8's stock price target?
Price Target
52.56
EUR
According to Wall Street analysts, the average 1-year price target for UR8 is 52.56 EUR with a low forecast of 41.64 EUR and a high forecast of 67.64 EUR.
What is the Revenue forecast for Urogen Pharma Ltd?
Projected CAGR
31%
The compound annual growth rate for Revenue over the next 8 years is 31%.
What is the Gross Profit forecast for Urogen Pharma Ltd?
Projected CAGR
31%
The compound annual growth rate for Gross Profit over the next 8 years is 31%.
